KARGER KOMPASS NEUMOLOGÍA
Published in Karger Kompass Neumología
Prólogo
Published in Karger Kompass Neumología
La pandemia de 2009 en México: Experiencia y lecciones sobre políticas nacionales de previsión contra la influenza estac...
Published in Karger Kompass Neumología
La influenza es una enfermedad viral respiratoria capaz de originar epidemias que representan una amenaza para la seguridad mundial. México fue el primer país que notificó a la Organización Mundial de la Salud sobre un brote que habría de convertirse en pandemia, la primera del siglo XXI causada por el virus A(H1N1)2009. Antes de ese evento, México...
Péptidos antimicrobianos, una alternativa prometedora para el tratamiento de enfermedades infecciosas
Published in Karger Kompass Neumología
Los microorganismos causantes de enfermedades en humanos evolucionan constantemente, lo que representa un reto en la búsqueda de tratamientos efectivos contra estos patógenos. Aun cuando en la actualidad se cuenta con diversas alternativas farmacológicas, estas en ocasiones resultan ineficientes para el control de las enfermedades infecciosas, sobr...
Predictores de la terminación de la terapia de presión positiva en las vías aéreas en pacientes con apnea obstructiva de...
Published in Karger Kompass Neumología
Background: There is a lack of robust data about factors predicting continuation (or termination) of positive airway pressure therapy (PAP) for sleep apnea. This analysis of big data from a German homecare provider describes patients treated with PAP, analyzes the therapy termination rate over the first year, and investigates predictive factors for...
Tuberculosis: Estrategias futuras para una enfermedad antigua
Published in Karger Kompass Neumología
The emergence and spread of drug-resistant strains of Mycobacterium tuberculosis is worsening the global threat of tuberculosis (TB). There is a need and urgency for the development of new treatments for TB, for the management of drug resistant TB (MDR-TB) and for improved regimens against drug-susceptible TB, with the goal of reducing toxicity and...
Enfermedad respiratoria crónica: Telerehabilitación versus rehabilitación pulmonar tradicional
Published in Karger Kompass Neumología
Background: Pulmonary rehabilitation is an effective therapeutic intervention for people with chronic respiratory disease. However, fewer than 5% of eligible individuals receive pulmonary rehabilitation on an annual basis, largely due to limited availability of services and difficulties associated with travel and transport. The Rehabilitation Exerc...
Prognostic Implications of Influenza Virus Infection in a Cardiac Intensive Care Unit: Potential Impact of a Screening P...
...Published in Cardiology
Objectives: Our goal was to determine the presentation and prognosis of influenza in an intensive cardiac care unit and to analyze the impact of an active surveillance program in the diagnosis. Methods: We performed a prospective registry during the flu season in a coronary unit. In the first phase, no systematic screening was performed. Systematic...
“Homomorphic” Tumor Metastases as an Endodiagnostic Clue: A Case Series of Renal-Cell Carcinoma Metastatic to the Stomac...
Published in Gastrointestinal Tumors
Distinguishing between a primary malignancy and a metastasis can be challenging in some cases. Herein, we describe 2 cases of gastric lesions that were endoscopically sampled and ultimately found to be metastatic from a renal-cell carcinoma. In both cases, the gastric metastases were endoscopically homomorphic to the primary organ (the kidney); i.e...
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experien...
...Published in Gastrointestinal Tumors
Background: Sorafenib has been established as the standard of care for patients with advanced hepatocellular carcinoma (HCC) since 2007 on the basis of two landmark trials (SHARP and Asia-Pacific). Ten years have passed since then and, despite much research in the field, still no validated real-life prognostic markers are available for HCC patients...
